Condition
Postimplantation Syndrome
Total Trials
4
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 4 (1)
Trial Status
Not Yet Recruiting2
Unknown1
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07328906Not ApplicableNot Yet RecruitingPrimary
Steroid Treatment to Prevent Thoracic Endovascular Aortic Repair Postimplantation Syndrome
NCT07014839CompletedPrimary
Post-Implantation Syndrome and Laboratory Markers Following EVAR and TEVAR
NCT06044480Phase 4Not Yet Recruiting
Effect of Dexamethason on Postimplantation Syndrome After EVAR
NCT05349071Not ApplicableUnknown
PreOperative Methylprednisolone on Thoracic Endovascular Repair for Reducing Post-implantation Syndrome (POMTEVAR)
Showing all 4 trials